CLINICAL_TRIALS
trial_result
· 2008-12-03
Clinical Trial Update: Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine) [Phase 4]
Summary
Phase 4 study update evaluating phenotypes in insulin-naive patients with type 2 diabetes treated with Lantus (insulin glargine).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED